Intas Pharmaceuticals Limited — Sanand
USFDA inspection record for FEI 3004011473, Sanand, India. Listed company: Intas Pharmaceuticals (unlisted).
OAI
Latest classification
1
Inspections on record
2
Form 483 observations on record
History (newest first)
Inspections
02 Dec 2022
OAI — Official action indicated
Drug Quality Assurance · Drugs · FY2023
Form 483: 2 observations
- Complete test data included in records (21 CFR 211.194(a))
- Results not used for expiration dates, storage cond. (21 CFR 211.166(a))
Source: FDA Data Dashboard ↗
FDA compliance actions
| Date | Action | Product type |
|---|---|---|
| 28 Jul 2023 | Warning Letter | Drugs |
📎 Cite this data: Source: PharmaRoz, FDA inspection record for FEI 3004011473, updated 12 Nov 2026